Nutrition Impact on Immunotherapy of Cancer
This study investigates nutritional status and outcomes of immuntherapy in cancer patients.
Nutrition Disorders|Immunotherapy|Cancer|Survival, Prosthesis
DRUG: Megestrol Acetate and olanzapine|DRUG: Starch powder 50 mg
ORR, overall response rate, 12 months
PFS, profression-free survival, 12 months
Studies have shown that more than half of the patients with cancer are also malnourished at diagnosis. This increases patients' risk of complications associated with the treatment as well as the abandonment of care, as well as decrease the level of survival rates.